Barclays lowered the firm’s price target on Avantor (AVTR) to $23 from $26 and keeps an Overweight rating on the shares post the Q4 report. The company reported a mixed quarter and guided below estimates, especially on Q1, which gives little confidence that Labs are going to improve throughout the year, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR:
- Avantor Reports 2024 Financial Results, Shows Growth Potential
- Avantor Earnings Call: Balanced Outlook Amid Challenges
- Avantor’s Strong Bioprocess Momentum and Cost Efficiency Justify Buy Rating Amid Market Challenges
- Morning Movers: Amazon slips after soft revenue guidance, big AI spending plans
- Options Volatility and Implied Earnings Moves Today, February 07, 2025